Skip to main content

PC-03 Antenatal Steroids

CBE ID
0476
1.4 Project
Perinatal and Women's Health
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Fall 2020
Is Under Review
No
1.3 Measure Description

This measure assesses patients at risk of preterm delivery at >=24 and <34 weeks gestation receiving antenatal steroids prior to delivering preterm newborns. This measure is a part of a set of five nationally implemented measures that address perinatal care (PC-01: Elective Delivery, PC-02: Cesarean Birth, PC-04: Health Care-Associated Bloodstream Infections in Newborns, PC-05: Exclusive Breast Milk Feeding; Beginning 1/1/2019 PC-06 Unexpected Complications in Term Newborns will be added).

    • 1.14 Numerator

      Patients with antenatal steroids initiated prior to delivering preterm newborns (refer to Appendix C, Table 11.0, antenatal steroid medications).

    • 1.15 Denominator

      Patients delivering live preterm newborns with >=24 and <34 weeks gestation completed with ICD-10-PCS Principal or Other Procedure Codes for delivery as defined in Appendix A, Table 11.01.1.

    • Exclusions

      • Less than 8 years of age
      • Greater than or equal to 65 years of age
      • Length of Stay >120 days
      • Documented Reason for Not Initiating Antenatal Steroids
      • ICD-10-CM Principal Diagnosis Code or ICD-10-CM Other Diagnosis Codes for fetal demise as defined in Appendix A, Table 11.09.1.
      • Gestational Age < 24 or >= 34 weeks or UTD

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Perinatal and Women's Health Fall Cycle 2020
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      The Joint Commission
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.